e2d5a769_Fungal_Pneumonia__ication_for_Antifungal_Therapy
[Fungal Pathogen] Blastomycosis Steroids for ARDS [Antifungal Drugs Used] Amphotericin B response rates of 77-90% of cases; for severe infection or immunocompromised Itraconazole successful in 90% of cases; for mild to moderate infection Ketoconazole response of 80%; poor outcome in patients who are immunosuppressed Fluconazole less effective, 65% response rate Chronic maintenance treatment essential for all patients with AIDS or meningitis
Persistent or recurrent symptoms of acute or chronic pulmonary disease or with pleural involvement; disseminated disease
Fungal Pneumonia
Indication for Antifungal Therapy